title: Urinary tract infection due toChryseobacterium gleum, an uncommon pathogen.
abstract: Chryseobacterium species are gaining importance as an emerging opportunistic nosocomial pathogen. Limited availability of clinical data necessitates reporting of such isolates. We report a case of nosocomial urinary tract infection by metallo-β-lactamase-producing Chryseobacterium gleum in an elderly diabetic male with chronic renal disease. Identification and antibiotic sensitivity test performed by conventional methods were confirmed by Matrix-assisted Laser Desorption Ionization Time-of-Flight and VITEK-2 systems, respectively. The patient responded well to intravenous ciprofloxacin therapy.
authors.affiliation: Department of Microbiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India.
authors.forename: Prabha
authors.initials: P
authors.lastname: Rajendran
authors.affiliation: Department of Microbiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India.
authors.forename: Swapna
authors.initials: S
authors.lastname: Muthusamy
authors.affiliation: Department of Microbiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India.
authors.forename: Vignesh K
authors.initials: VK
authors.lastname: Balaji
authors.affiliation: Department of Microbiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India.
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Rakesh
authors.affiliation: Department of Microbiology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry, India.
authors.forename: Joshy M
authors.initials: JM
authors.lastname: Easow
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D015373:Bacterial Typing Techniques; D045247:Chryseobacterium / Q000145:classification / Q000187:drug effects / Q000201:enzymology / Q000302:isolation & purification*; D002939:Ciprofloxacin / Q000008:administration & dosage; D048909:Diabetes Complications; D045826:Flavobacteriaceae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D001618:beta-Lactamases